Network Pharmacology Combined With Gut Microbiome and Serum Metabolomics Reveals the Therapeutic Mechanisms of Hydroxysafflor Yellow A in Diabetic Kidney Disease.
Saved in:
| Title: | Network Pharmacology Combined With Gut Microbiome and Serum Metabolomics Reveals the Therapeutic Mechanisms of Hydroxysafflor Yellow A in Diabetic Kidney Disease. |
|---|---|
| Authors: | Wang, Pingping1 (AUTHOR), Liu, Xinyu2 (AUTHOR), Sun, Wen3 (AUTHOR), Dong, Xueyun4 (AUTHOR), Tan, Jiajun4 (AUTHOR), Chen, Min4 (AUTHOR), He, Jiayuan5 (AUTHOR), Ali, Asmaa4,6 (AUTHOR), Wu, Liang4 (AUTHOR) wl_ujs@163.com, Shao, Keke2,7 (AUTHOR) keke87890394@163.com, Cui, Huantian (AUTHOR) cuihuantian@ynucm.edu.cn |
| Source: | Journal of Diabetes Research. 4/1/2026, Vol. 2026, p1-19. 19p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
